Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addressing Fear of Cancer Recurrence in Parents of Pediatric Cancer Survivors: Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

NCT06872840 is registered in ClinicalTrials.gov with University of Ottawa as lead sponsor.

NCT NCT06872840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06872840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addressing Fear of Cancer Recurrence in Parents of Pediatric Cancer Survivors: Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility
Lead sponsor
University of Ottawa
Phase
Not applicable
Overall status
Recruiting
Start date
August 26, 2025
Completion date
May 26, 2027
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cbt, childhood cancer survivors, fear of cancer recurrence, parent